RxDoctor Payments Data

Arlette Soros Dupre

Pediatric Endocrinology · New Orleans, LANPI 1073706339

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 13.1% — the pattern of someone who eats at a lot of different presentations.

$2,262in general payments, 2019–2025

Across 97 payments — averaging $23.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dexcom, Inc.$297
  • Ascendis Pharma Endocrinology Inc$287
  • Novo Nordisk$272
  • AbbVie$165
  • Sanofi-aventis U.S. LLC$158
  • Pfizer$138
  • plus $945 from 21 others

What the payments were for

  • Food & beverage$2,262100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric endocrinology providers in Louisianato place this figure against a meaningful peer group, so we don't.

Other pediatric endocrinology in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →